Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
Supplementary Table 1. Optimum immunotherapy method according to PD-L1 expression in advanced lung cancer: a network meta-analysisBayesian ranking results of network meta-analysis. PlaCT= platinum-bas
agender, smoking, stage and grade were adjusted in multivariate analysis. Multivariate analysis of the influence of various parameters in PD-L1 on overall survival in OSCC patients.
Primary outcome(s): Correlation between PD-L1 expression in immune cells and soluble PD-L1 value. Correlation between PD-L1 expression in immune cells or soluble PD-L1 value and PD-L1 expression in tu